Reports Q2 revenue $2.86B, consensus $2.92B. “We believe the individual market has long-term upside and is the future of healthcare,” said Mark Bertolini, CEO of Oscar Health (OSCR). “Oscar is well-positioned to manage through the market reset in 2025. We believe the market will stabilize next year, and expect to return to profitability in 2026. We are building the individual market into a healthcare marketplace for more consumers and businesses, and continue to position the company for long-term growth.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OSCR:
- Option traders moderately bearish in Oscar Health with shares down 0.98%
- Mixed options sentiment in Oscar Health with shares down 3.92%
- Mixed options sentiment in Oscar Health with shares down 2.39%
- Baird downgrades Oscar Health on healthcare exchange uncertainty
- Oscar Health downgraded to Neutral from Outperform at Baird